LLY

1,088.53

+1.81%↑

JNJ

223.67

-0.06%↓

ABBV

218.6

+1.58%↑

UNH

381.21

+1.28%↑

MRK

114.86

-1.37%↓

LLY

1,088.53

+1.81%↑

JNJ

223.67

-0.06%↓

ABBV

218.6

+1.58%↑

UNH

381.21

+1.28%↑

MRK

114.86

-1.37%↓

LLY

1,088.53

+1.81%↑

JNJ

223.67

-0.06%↓

ABBV

218.6

+1.58%↑

UNH

381.21

+1.28%↑

MRK

114.86

-1.37%↓

LLY

1,088.53

+1.81%↑

JNJ

223.67

-0.06%↓

ABBV

218.6

+1.58%↑

UNH

381.21

+1.28%↑

MRK

114.86

-1.37%↓

LLY

1,088.53

+1.81%↑

JNJ

223.67

-0.06%↓

ABBV

218.6

+1.58%↑

UNH

381.21

+1.28%↑

MRK

114.86

-1.37%↓

Accueil・Liste d'Actions・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Ouvert

SecteurSoins de santé

15.51 -2.51

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

15.3

Max

Chiffres clés
By Trading Economics
Revenu	-2.9M -4.6M
Ventes	-43M 392M
BPA	0.54
Marge bénéficiaire	-1.178
Employés	4,427
EBITDA	13M 79M

Recommandations
By TipRanks
Recommandations	Neutre
Prévisions sur 12 Mois	+14.87% upside

Dividendes
By Dow Jones
Prochains Résultats	30 juil. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	389M 1.2B
Ouverture précédente	18.02
Clôture précédente	15.51

Sentiment de l'Actualité

By Acuity

26%

74%

63 / 344 Classement par Healthcare

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 juin 2026, 20:30 UTC

Résultats

Palo Alto Networks 3Q Revenue Rises as Customers Beef Up Cyber Defenses

2 juin 2026, 23:58 UTC

Market Talk

Australia's Consumer Sector Expected to Be Stung by Housing Downturn -- Market Talk

2 juin 2026, 23:46 UTC

Market Talk

Global Equities Roundup: Market Talk

2 juin 2026, 23:46 UTC

Market Talk

Nikkei May Rise as AI Demand Hopes Continue -- Market Talk

2 juin 2026, 23:41 UTC

Market Talk

Oil Rises Amid Signs of U.S.-Iran Peace Talks Stalling -- Market Talk

2 juin 2026, 23:01 UTC

Acquisitions, Fusions, Rachats

ACCC Says Owner of Metro Petroleum Brand to Buy the 41 Sites

2 juin 2026, 23:01 UTC

Acquisitions, Fusions, Rachats

ACCC Says Ampol Must Sell 41 Retail Fuel Sites to an Approved Purchaser

2 juin 2026, 23:00 UTC

Acquisitions, Fusions, Rachats

Australia's Competition Regulator Approves Ampol's Purchase of EG Australia With Conditions

2 juin 2026, 22:57 UTC

Market Talk

Australian Dollar Could Fall Following 1Q GDP Data -- Market Talk

2 juin 2026, 22:50 UTC

Market Talk

Ulta Beauty Says TikTok Shop Will Provide 'Halo' Effect -- Market Talk

2 juin 2026, 21:07 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2 juin 2026, 21:07 UTC

Market Talk

Tokenized Assets Need Access to Digital-Finance Plumbing -- Market Talk

2 juin 2026, 21:00 UTC

Résultats

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2 juin 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

2 juin 2026, 20:46 UTC

Résultats

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2 juin 2026, 20:38 UTC

Résultats

GitLab Stock Rises as the Software Company Raises Guidance on AI Business Momentum -- Barrons.com

2 juin 2026, 20:21 UTC

Résultats

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2 juin 2026, 20:12 UTC

Résultats

Palo Alto Stock Jumps on Strong Earnings -- Barrons.com

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks 3Q Product Rev $594M

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Sees FY26 Next-Generation Security ARR $8.9B-$8.95B

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Raises FY26 View To Adj EPS $3.77-Adj EPS $3.79 >PANW

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks 3Q Subscription and Support Rev $2.41B

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Sees FY26 Remaining Performance Obligation $20.9B-$21B

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Sees 4Q Rev $3.345B-$3.355B >PANW

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Sees 4Q Adj EPS 96c-Adj EPS 98c >PANW

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks on Track to Achieve 40% Adj Free Cash Flow Margin in FY28

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks Raises FY26 View To Rev $11.415B-$11.425B >PANW

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks 3Q Remaining Performance Obligation $18.4B

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks 3Q Adj EPS 85c >PANW

2 juin 2026, 20:05 UTC

Résultats

Palo Alto Networks 3Q Loss $177M >PANW

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

14.87% hausse

Prévisions sur 12 Mois

Moyen 18 USD 14.87%

Haut 27 USD

Bas 14 USD

Basé sur 6 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

6 ratings

Achat

Maintien

Vente

Basé sur 6 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Sentiment

By Acuity

63 / 344Classement par Soins de santé

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.